Clinical Trial Update: Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating early use of levosimendan on top of conventional inotrope therapy to improve a combined morbidity-mortality endpoint in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Pr Bruno LEVY | Conditions: Cardiogenic Shock | Phase 3 | Status: RECRUITING